Categories: NewsPharmaceutical

LaVoieHealthScience Welcomes Katie Dodge as Senior Vice President and General Manager

Focus on Agency, Client Excellence, Growth, People and Best Practices

BOSTON & NEW YORK–(BUSINESS WIRE)–LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the expansion of its senior leadership team with the appointment of Katie Dodge as Senior Vice President and General Manager of its Boston headquarters.


In her role, Katie is responsible for agency and client excellence in both LHS’ commercial and emerging communication practices with a focus on growth, people, and best practices. She brings a wealth of communications expertise to LHS clients including corporate and product communications media strategy and execution, brand development and management, social media strategy, people management, executive media training, message development and crisis communications.

Donna L. LaVoie, President and Chief Executive Officer of LaVoieHealthScience said, “Katie brings an entrepreneurial mindset to our agency and a record of accomplishment of client success across a portfolio pharmaceutical, biopharma, life science, medical technology, and related fields. We are excited to experience Katie’s leadership with our team and clients, who are dedicated to advancing health and science innovations globally.”

Katie’s entire career has been spent at leading health- oriented communications agencies, including Ruder Finn, Salutem, JPA Health, Weber Shandwick, KYNE, and Edelman. Katie is a graduate of Emerson College with a Bachelor of Science in Marketing Communications.

About LaVoieHealthScience

LaVoieHealthScience partners with health and science emerging and commercial organizations to advance their innovations. The complexity of the business of science, medicine, and technology requires leaders to create a unique voice in a highly regulated industry. We guide leaders using our 20+ years of history with modern perspectives and time-tested results. Our programs include strategic positioning, public relations and marketing, investor relations, corporate communications, and digital and creative services.

For more information, please visit lavoiehealthscience.com and connect with us on LinkedIn, X, and Facebook.

Contacts

Agency Contact:

Lisa DeScenza

SVP, Corporate Communications & Investor Relations

(617) 351-0243

ldescenza@lavoiehealthscience.com

Media Contact:

Abby Ramsay

Account Supervisor

(617) 865-9340

aramsay@lavoiehealthscience.com

Staff

Recent Posts

Annual 2024 Home Care 100 Gathering: Exploring New Frontiers

Home Care 100's June gathering served as a critical platform for advancing dialogue around growth,…

4 hours ago

Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today…

10 hours ago

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the…

10 hours ago

TraceLink MINT Awarded 2024 Supply Chain Visibility Solution of the Year by SupplyTech Breakthrough

TraceLink Recognized with Top Honor in Supply Chain Visibility at SupplyTech Breakthrough Awards BOSTON, June 13,…

10 hours ago

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Meeting will be reconvened on Friday, June 14, 2024 at 10:00 a.m. Eastern Time  PHILADELPHIA,…

10 hours ago